Fill It Up: Pfizer To Consider More Flexible Deals, Alliances To Bolster Pipeline

Acknowledging a lack of depth in the late-stage pipeline, Pfizer CEO Jeff Kindler said the company will use creative deal structures to add innovative drugs and biotherapeutics to its portfolio, despite the competitive market and resulting high prices for such products